Report #2836136

Received Apr 15, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: IA
Recovered: Unknown
Vaccinated: Feb 21, 2022
Onset: Feb 21, 2022
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
MMRV	MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD)	MERCK & CO. INC.	1	T025509	—

Symptoms (2)

Expired product administeredNo adverse event

Symptom narrative

no adverse event; expired vaccine administered; This spontaneous report was received from an Other health professional and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 21-Feb-2022, the patient started therapy with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #T025509, expiration date: 23-Jan-2022, also reported as 23-JAN-2025, discrepancy) (1 dose) reconstituted with sterile diluent (DSM STERILE DILUENT), (lot # and expiration date were not reported)(expired vaccine administered) No adverse event was reported.

Other medications

Sterile diluent